先天性巨细胞病毒感染的评估与管理
综述面向妇产科医生,更新先天性巨细胞病毒(CMV)感染的评估与管理,并为孕期原发性感染或再激活/再感染风险者的咨询提供框架。先天性CMV感染风险取决于母体感染时的孕龄及感染类型,早期感染风险较低但临床后遗症更重。美国指南目前不推荐常规筛查孕妇CMV感染;早孕期确诊原发感染时,新出现的数据支持考虑母体抗病毒治疗以预防先天性CMV感染。
要点
- CMV是最常见的先天性病毒感染及美国最常见的非遗传性儿童听力损失原因。
- 先天性CMV感染风险取决于母体感染时孕龄及原发性或非原发性感染。
- 美国指南目前不推荐常规筛查孕妇CMV感染,多数州不强制新生儿普遍筛查。
核心结论
- 综述更新了先天性CMV感染的评估与管理框架,供妇产科医生为孕期原发性CMV感染或再激活/再感染风险者提供咨询。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- CMV是一种DNA病毒,是美国最常见的先天性病毒感染及非遗传性儿童听力损失的最常见原因。
- 先天性CMV感染风险取决于母体感染时的孕龄以及感染为原发性或非原发性。
- 孕龄较早时感染,先天性CMV感染风险较低,但母体感染越早,临床后遗症越严重。
- 早孕期确诊母体原发性感染时,新出现的数据支持考虑母体抗病毒治疗以预防先天性CMV感染。
- 先天性CMV感染确诊后(通常在产前超声异常后),母体抗病毒治疗效用的数据较为有限。
关键数值与推荐
- 美国指南目前不推荐常规筛查母体CMV感染。
- 美国多数州目前不强制要求新生儿普遍筛查先天性CMV感染。
- 确诊先天性CMV感染的新生儿接受广泛评估以确定是否存在神经系统症状,从而指导产后评估与管理。
临床怎么用
- 妇产科医生可依据本综述为存在孕期原发性CMV感染或再激活/再感染风险者提供咨询。
- 早孕期确诊母体原发性感染时,新出现的数据支持考虑母体抗病毒治疗以预防先天性CMV感染。
- 先天性CMV感染确诊后,母体抗病毒治疗效用的数据较为有限。
- 确诊先天性CMV感染的新生儿需广泛评估神经系统症状,以指导产后评估与管理。
局限性
- 先天性CMV感染确诊后,母体抗病毒治疗效用的数据较为有限。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of this review is to serve as an update on congenital cytomegalovirus (CMV) evaluation and management for obstetrician-gynecologists and to provide a framework for counseling birthing people at risk for or diagnosed with a primary CMV infection or reactivation or reinfection during pregnancy. A DNA virus, CMV is the most common congenital viral infection and the most common cause of nongenetic childhood hearing loss in the United States. The risk of congenital CMV infection from transplacental viral transfer depends on the gestational age at the time of maternal infection and whether the infection is primary or nonprimary. Although the risk of congenital CMV infection is lower with infection at earlier gestational ages, clinical sequelae are more severe with maternal infections earlier in gestation. At present, routine screening for maternal CMV infection is not recommended by U.S. guidelines. When maternal primary infection is confirmed in early pregnancy, emerging data support consideration of maternal antiviral therapy to prevent congenital CMV infection. When congenital CMV infection is confirmed, typically after an abnormal prenatal ultrasound result, there are more limited data on the utility of maternal antiviral therapy. Universal newborn screening for congenital CMV infection is not mandatory in most U.S. states at present. Newborns diagnosed with congenital CMV infection undergo an extensive evaluation to determine whether neurologic symptoms are present, which guides postnatal evaluation and management. In this review, we discuss the diagnosis and management of maternal CMV infection, the risk and diagnosis of congenital CMV infection, prevention and potential treatment of congenital CMV infection in utero, and neonatal congenital CMV infection diagnosis and management.
引用
- Coskun E, Kakkar F, Riley LE, et al. Evaluation and Management of Congenital Cytomegalovirus Infection. Obstet Gynecol. 2025. PMID: 39847776. doi:10.1097/AOG.0000000000005840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。